Observational studyEuropean journal of endocrinology2018

Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant.

Christian J Strasburger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.